23
Participants
Start Date
November 10, 2021
Primary Completion Date
March 31, 2024
Study Completion Date
March 31, 2024
Dopaminergic OFF-drug state
Dopaminergic OFF-drug state: Overnight withdrawal of dopaminergic antiparkinsonian drugs during visit 3 or 4. The sequence of drug conditions (dopaminergic OFF-drug/ON-drug state or ON-drug/OFF-drug state) will be randomized.
Dopaminergic ON-drug state
Dopaminergic ON-drug state: Patient will be evaluated in his/her regular treatment in dopaminergic ON-drug state at visit 3 or 4. The sequence of drug conditions (dopaminergic OFF-drug/ON-drug state or ON-drug/OFF-drug state) will be randomized.
EPFL Campus Biotech, Geneva
EPFL Institute of Bioengineering, Geneva
University Hospital Geneva (HUG), Geneva
University Hospital Inselspital, Berne, Bern
University Hospital, Geneva
OTHER
Ecole Polytechnique Fédérale de Lausanne
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER